EICHORPublic-registry site landscape for NCT06290388, “Study of 23ME-01473 in Patients With Advanced Solid Malignancies”, a Solid Tumor study sponsored by 23andMe, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06290388 (registry record) |
| Study title | Study of 23ME-01473 in Patients With Advanced Solid Malignancies |
| Official title | A Phase 1/2a, Multicenter, Open-label, Dose Escalation and Expansion Study of Intravenously Administered 23ME-01473 in Participants With Advanced Solid Malignancies |
| Sponsor | 23andMe, Inc. |
| Condition(s) | Solid Tumor |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 3 |
| Intervention(s) | 23ME-01473 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06290388.
Eichor generates a preliminary site-risk snapshot for NCT06290388 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Solid Tumor trials
← Eichor home · All tracked trials · Solid Tumor studies · Weekly briefs
